129 results match your criteria: "and The University of Missouri-Kansas City[Affiliation]"
World J Transplant
December 2024
Department of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 48109, United States.
Background: Prostaglandin E1 (PGE1), or alprostadil, is a potent vasodilator that improves hepatic blood flow and reduces ischemia-reperfusion injury post-liver transplantation (LT). However, the benefits of PGE1 on renal function after LT have not yet been well described.
Aim: To assess the impact of PGE1 administration on renal function in patients who underwent liver or liver-kidney transplant.
Postgrad Med
May 2024
Division of Cardiovascular Diseases, University Health Truman Medical Center and the University of Missouri-Kansas City Kansas City, Kansas City, MO, USA.
For decades, we have been treating patients presenting with angina and concerning electrocardiographic changes indicative of ischemia or injury, in whom no culprit epicardial coronary stenosis was found during diagnostic coronary angiography. Unfortunately, the clinical outcomes of these patients were not better than those with recognized obstructive coronary disease. Improvements in technology have allowed us to better characterize these patients.
View Article and Find Full Text PDFJACC Heart Fail
September 2024
School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Background: In the REVIVED-BCIS2 (Revascularization for Ischemic Ventricular Dysfunction) trial, percutaneous coronary intervention (PCI) did not reduce the incidence of death or hospitalization for heart failure (HHF).
Objectives: This prespecified secondary analysis investigated the effect of PCI on health status measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ) combined with the primary outcome in a win ratio.
Methods: Participants with severe ischemic left ventricular dysfunction were randomized to either PCI in addition to optimal medical therapy (OMT) (PCI) or OMT alone (OMT).
J Pediatr Pharmacol Ther
November 2023
Division of Clinical Pharmacology (NM, ZD, ET), Indiana University School of Medicine, Indianapolis, IN.
Purpose: Etoposide, a topoisomerase II inhibitor used clinically to treat cancer, has been associated with severe anaphylactic infusion related adverse drug reactions (ADRs). In a previous study we identified a hydrophilic polyethersulfone filter as a possible cause of increased rates of pediatric etoposide infusion reactions. In this multidisciplinary follow-up analytical study, we aimed to assess the chemical structure of etoposide after passing through the same hydrophilic polyethersulfone filter.
View Article and Find Full Text PDFJ Nucl Cardiol
December 2023
Cardiovascular Imaging Technologies, Kansas City, MO, USA.
Introduction: Myocardial perfusion imaging (MPI) protocols have not changed significantly despite advances in instrumentation and software. We compared an early post-injection, stress-first SPECT protocol to standard delayed imaging.
Methods: 95 patients referred for SPECT MPI were imaged upright and supine on a Spectrum Dynamics D-SPECT CZT system with CT attenuation correction.
Vasc Med
June 2023
Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, School of Medicine, Kansas City, MO, USA.
Ann Allergy Asthma Immunol
April 2023
Allergy, Asthma and Immunology, Children's Mercy Hospital and The University of Missouri-Kansas City School of Medicine, Kansas City, Missouri. Electronic address:
J Nucl Cardiol
June 2023
Department of Cardiology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
World J Hepatol
February 2023
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Liver Disease Management Unit, Saint Luke's Health System of Kansas City and the University of Missouri-Kansas City, Kansas City, MO 64111, United States.
Am Heart J Plus
March 2023
Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
J Am Acad Orthop Surg
April 2023
From the Department of Orthopaedic Surgery (McNassor, Grits, Burkhart Dr. Acuña, Dr. Kamath), Cleveland Clinic Foundation, Cleveland, OH (McNassor, Grits, Burkhart, Acuña, and Kamath), and the University of Missouri-Kansas City School of Medicine, Kansas City, MO (Said).
Introduction: Although previous studies have demonstrated inconsistencies between surgeon work and reimbursement, no previous study has calculated expected relative value units (RVUs) based on procedure-specific variables. Our study aimed to evaluate how measures of physician workload and surgical complexity correlate with the work RVUs (wRVUs) assigned to orthopaedic procedures and compare our predicted wRVUs with actual wRVUs.
Methods: The National Surgical Quality Improvement Program was used to identify orthopaedic surgeries with the highest procedural volume in 2019.
Background: A recent study suggested that women with out-of-hospital cardiac arrest have a smaller survival benefit with bystander cardiopulmonary resuscitation than men. We evaluated whether this weaker association between bystander cardiopulmonary resuscitation and survival in women is related to dispatcher-assisted vs unassisted bystander cardiopulmonary resuscitation.
Methods: In a national registry in the Republic of Korea, we identified adult patients with out-of-hospital cardiac arrest during 2013-2018.
Circ Cardiovasc Qual Outcomes
February 2023
Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, MO (P.S.C.).
Circ Cardiovasc Qual Outcomes
October 2022
Background: Most studies on out-of-hospital cardiac arrest have primarily focused on in-hospital or short-term survival. Little is known about long-term outcomes and resource use among survivors of out-of-hospital cardiac arrest.
Methods: In this observationsl study, we describe overall long-term outcomes for patients from the national Cardiac Arrest Registry to Enhance Survival linked to Medicare files to create the Cardiac Arrest Registry to Enhance Survival: Mortality, Events, and Costs for Cardiac Arrest survivors dataset.
Resuscitation
January 2023
Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, MO, USA. Electronic address:
Background: Prior studies have identified socio-cultural barriers in laypersons performing high-quality cardiopulmonary resuscitation (CPR) in women. Whether the effect of layperson bystander CPR on survival from out-of-hospital cardiac arrest (OHCA) differs by patients' sex is unknown.
Methods: Using data during 2013-2020 from an OHCA registry in the U.
JAMA Cardiol
November 2022
University of British Columbia, Vancouver, British Columbia, Canada.
Importance: In patients with multivessel coronary artery disease (CAD) presenting with ST-segment elevation myocardial infarction (STEMI), complete revascularization reduces major cardiovascular events compared with culprit lesion-only percutaneous coronary intervention (PCI). Whether complete revascularization also improves angina-related health status is unknown.
Objective: To determine whether complete revascularization improves angina status in patients with STEMI and multivessel CAD.
Semin Perinatol
November 2022
Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
At the inception of the Eunice Kennedy Shriver National Institute of Child Health and Development Neonatal Research Network (NRN), provision of care for extremely preterm (EPT) infants was considered experimental. The NRN Follow-up Study Group, initiated in 1993, developed infrastructure with certification processes and standards, allowing the NRN to assess 2-year outcomes for EPT and to provide important metrics for randomized clinical trials. This chapter will review the NRN Follow-up Study Group's contributions to understanding factors related to improved neurodevelopmental, behavioral, and social-emotional outcomes of EPT infants.
View Article and Find Full Text PDFBackground There are limited data on the use of angiotensin receptor neprilysin inhibitors (ARNIs) in minority populations with heart failure (HF) with reduced ejection fraction. We used data from the CHAMP-HF (Change the Management of Patients With Heart Failure) registry to evaluate ARNI initiation and associated changes in health status and clinical outcomes across different races and ethnicities. Methods and Results CHAMP-HF was a prospective, observational registry of US outpatients with chronic HF with reduced ejection fraction.
View Article and Find Full Text PDFPharmacoecon Open
July 2022
MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Background: Hypertrophic cardiomyopathy (HCM) symptoms include shortness of breath (SOB), fatigue, chest pain, palpitations, dizziness, and fainting. The HCM Symptom Questionnaire (HCMSQ), the only patient-reported outcome instrument designed to specifically measure HCM symptoms, yields four domain scores (SOB, tiredness, cardiovascular symptoms, syncope) and a total score. We evaluated the longitudinal psychometric properties of the HCMSQ using baseline to week 30 data from the phase III EXPLORER-HCM trial (NCT03470545).
View Article and Find Full Text PDFNat Rev Cardiol
November 2022
Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
The majority of cardiovascular randomized controlled trials (RCTs) test interventions in selected patient populations under explicitly protocol-defined settings. Although these 'explanatory' trial designs optimize conditions to test the efficacy and safety of an intervention, they limit the generalizability of trial findings in broader clinical settings. The concept of 'pragmatism' in RCTs addresses this concern by providing counterbalance to the more idealized situation underpinning explanatory RCTs and optimizing effectiveness over efficacy.
View Article and Find Full Text PDFJ Card Fail
July 2022
Saint Luke's Mid America Heart Institute and the University of Missouri- Kansas City, Kansas City, Missouri. Electronic address:
Background: There are limited data regarding the management of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) with virtual visits in comparison with in-office visits. We sought to compare the changes in GDMT (angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, angiotensin receptor neprilysin inhibitors, mineralocorticoid receptor antagonists, and sodium glucose cotransporter-2 inhibitors) and loop diuretics across visit types.
Methods And Results: This study included 13,481 outpatient visits performed for 5439 unique patients with HFrEF between March 16, 2020, and March 15, 2021.
Eur J Heart Fail
May 2022
Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Aims: We assessed for an association between improvements in left ventricular ejection fraction (LVEF) and future outcomes, including health status, in routine clinical practice.
Methods And Results: CHAMP-HF was a registry of outpatients with heart failure (HF) and LVEF ≤40%. Enrolled participants completed the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) at regular intervals and were followed as part of routine care.
Hosp Pediatr
April 2022
jDivisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Background: Although pediatric health care use declined during the coronavirus disease 2019 (COVID-19) pandemic, the impact on children with complex chronic conditions (CCCs) has not been well reported.
Objective: To describe the impact of the pandemic on inpatient use and outcomes for children with CCCs.
Methods: This multicenter cross-sectional study used data from the Pediatric Health Information System.